FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 11/05/2004 |
3. Issuer Name and Ticker or Trading Symbol
NUTRA PHARMA CORP [ NPHC ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 500,000(1) | D | |
Common Stock | 1,000(2) | D | |
Common Stock | 1,500(3) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
1. On November 5, 2004, Nutra Pharma Corp. issued 500,000 shares of its common stock, valued at $.34 per share, to Dr. Stewart Lonky for services to be rendered as a member of Nutra Pharma Corp.'s Board of Directors. |
2. On October 24, 2003, the Stewart A. Lonky M.D. Profit Sharing Plan and Trust purchased 1,000 shares of Nutra Pharma Corp. common stock at a price of $.25 per share, or an aggregate price of $250, in the open market, for investment purposes. Dr. Lonky is the beneficiary of the Stewart A. Lonky M.D. Profit Sharing Plan and Trust. |
3. Stewart A. Lonky jointly owns with his wife, Marilyn P. Lonky, a total of 1,500 shares of Nutra Pharma Corp. common stock. On January 7, 2003, Dr. and Mrs. Lonky purchased 500 shares at a price of $.43 per share, or an aggregate price of $215, in the open market, for investment purposes. On April 28, 2003, Dr. and Mrs. Lonky purchased 1,000 shares at a price of $.27 per share of Nutra Pharm Corp. common stock, or an aggregate price of $270, in the open market, for investment purposes. |
/s/Stewart A. Lonky | 04/20/2005 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |